18.97.14.84
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Gastroenterology

FDA approves Omvoh for Crohn’s disease, expanding treatment options for inflammatory bowel disease

The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz; Eli Lilly) for treating adults with moderately to severely active Crohn's disease, expanding its use to a second major type of inflammatory bowel disease, according to a press release. This approval is based on positive results from the Phase 3...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-